CLP36's Role in Lymphoma and Its Signaling Pathway
Author Information
Author(s): Lv Chao, Chen Guannan, Lv Shuang
Primary Institution: Inner Mongolia People’s Hospital, Hohhot, China
Hypothesis
This study aims to explore the involvement of CLP36 in lymphoma and its association with the PI3K/AKT/CREB signaling pathway.
Conclusion
The study provides evidence that CLP36 is involved in lymphoma progression and may serve as a potential therapeutic target.
Supporting Evidence
- CLP36 expression was higher in lymphoma and linked to poor prognosis.
- Silencing CLP36 reduced lymphoma cell survival and increased apoptosis.
- CLP36 silencing decreased levels of metastasis-related proteins CDH2 and VIM.
Takeaway
Researchers found that a protein called CLP36 helps lymphoma cells grow, and when they turned it off, the cancer cells died more easily.
Methodology
The study used qPCR, CCK-8 assays, colony formation assays, EdU staining, and flow cytometry to assess CLP36 expression and its effects on lymphoma cells.
Limitations
The study had a relatively small number of patient samples and did not fully explore the clinical applications of CLP36.
Statistical Information
P-Value
p<0.05
Statistical Significance
p<0.05
Digital Object Identifier (DOI)
Want to read the original?
Access the complete publication on the publisher's website